Benzinga | Nov 19, 2020 04:09PM EST

Aziyo Biologics Q3 EPS $(15.79) Down From $(4.81) YoY, Sales $11.80M Beat $11.21M Estimate

Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(15.79) per share. This is a 228.27 percent decrease over losses of $(4.81) per share from the same period last year. The company reported quarterly sales of $11.80 million which beat the analyst consensus estimate of $11.21 million by 5.26 percent.